Recent changes to recommendations for respiratory vaccines have left patients and providers with pressing questions about vaccine access and coverage. Following its most recent meeting in September, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended COVID-19 vaccines for those 6 months and older based on “individual decision-making.” This change in recommendation illuminated the need for stakeholders to have clarity on the impact of ACIP recommendations on respiratory vaccine insurance coverage.
CVEEP hosted a timely discussion on this topic as experts in healthcare coverage, public health, and vaccine policy broke down the relationship between ACIP recommendations and coverage among different types of insurance plans, what to expect at your vaccination appointments this year, and how to advocate for yourself as a patient seeking fall vaccines.
Panelists included:
August is National Immunization Awareness Month (NIAM), a time for us to recognize the critical role vaccination plays in helping prevent serious illness from infectious respiratory diseases. This annual observance highlights the importance of staying up to date with vaccines at all ages, especially as we approach the fall and winter respiratory season.
CVEEP hosted an expert-led discussion on the recent shifts to the federal vaccine landscape, what experts are anticipating ahead of the 2025/2026 respiratory season, and the potential impact of these changes on access and uptake this fall. Providers and public health experts explained the importance of staying up to date on vaccinations for infectious respiratory diseases and broke down the latest vaccine recommendations and guidance — offering insights into which vaccines are needed to stay protected throughout the fall and winter.
Panelists included:
As public health experts anticipate a rise in COVID-19 infections this summer, ensuring access to antiviral treatments for older adults and those with existing health conditions that make them vulnerable to serious illness is more important than ever.
CVEEP held a briefing featuring leading healthcare voices for an in-depth discussion on the current treatment landscape, highlighting the essential role antivirals play in preventing severe illness and hospitalization. The conversation explored key barriers to access, including under-prescription, cost, and insurance coverage, as well as strategies to raise awareness, improve uptake, and ensure that vulnerable populations can receive these life-saving treatments without delay.
Panelists included:
